Reports for AMGEN CANADA INC
Company Name
AMGEN CANADA INC
Shortage reports
Actual shortage:
0 (0%)
Anticipated shortage:
0 (0%)
Avoided shortage:
0 (0%)
Resolved:
4 (100%)
4
Discontinuation Reports
To be discontinued:
1 (25%)
Discontinued:
3 (75%)
Reversed:
0 (0%)
4
0 (0%)
1 (100%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NEUPOGEN | 300MCG | SOLUTION | Resolved | 2025-02-17 | 2025-03-25 | 250477 |
| SENSIPAR | 30MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230090 |
| SENSIPAR | 60MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230105 |
| SENSIPAR | 90MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230112 |
Showing 1 to 4 of 4
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| REPATHA | 120MG | SOLUTION | To be discontinued | 2024-03-26 | 2025-01-06 | 223420 |
| SENSIPAR | 30MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237894 |
| SENSIPAR | 60MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237897 |
| SENSIPAR | 90MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237900 |
Showing 1 to 4 of 4